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Chondroitin sulfate proteoglycans and heparan sulfate proteoglycans are major
constituents of the extracellular matrix and the cell surface in the brain. Proteoglycans
bind with many proteins including growth factors, chemokines, axon guidance
molecules, and cell adhesion molecules through both the glycosaminoglycan and
the core protein portions. The functions of proteoglycans are flexibly regulated
due to the structural variability of glycosaminoglycans, which are generated by
multiple glycosaminoglycan synthesis and modifying enzymes. Neuronal cell surface
proteoglycans such as PTPζ , neuroglycan C and syndecan-3 function as direct receptors
for heparin-binding growth factors that induce neuronal migration. The lectican family,
secreted chondroitin sulfate proteoglycans, forms large aggregates with hyaluronic
acid and tenascins, in which many signaling molecules and enzymes including matrix
proteases are preserved. In the developing cerebrum, secreted chondroitin sulfate
proteoglycans such as neurocan, versican and phosphacan are richly expressed in
the areas that are strategically important for neuronal migration such as the striatum,
marginal zone, subplate and subventricular zone in the neocortex. These proteoglycans
may anchor various attractive and/or repulsive cues, regulating the migration routes of
inhibitory neurons. Recent studies demonstrated that the genes encoding proteoglycan
core proteins and glycosaminoglycan synthesis and modifying enzymes are associated
with various psychiatric and intellectual disorders, which may be related to the defects
of neuronal migration.
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tor; GlcN, glucosamine; GlcNAc, N-acetylglucosamine: GPI, glycosylphosphatidylinositol; ECM, extracellular matrix; HAS,
hyaluronan synthase; Hh, hedgehog; HS, heparan sulfate; H2ST, heparan sulfate 2-O-sulfotransferase; H3ST, heparan sulfate
3-O-sulfotransferase; H6ST, heparan sulfate 6-O-sulfotransferase; HS C5-EP, heparan sulfate C5-epimerase; IdoA, iduronic
acid; LAR, leukocyte common antigen-related phosphatase; NDST, N-deacetylase/N-sulfotransferase; NGF, nerve growth
factor; NT, neurotrophin; ptc, patched; PHF, plant homeodomain finger; PHD, plant homeodomain; Sema, semaphorin; UST,
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Introduction
The extracellular matrix (ECM) is a complex network of
molecules composed of proteoglycans, hyaluronic acid,
fibrous proteins, and various glycoproteins, which fills up the
extracellular space within all tissues and organs (Mouw et al.,
2014). The ECM also retains water and ions, and constitutes
the direct environment surrounding cells, in which multiple
types of molecules are cross-linked to each other through
protein-protein and protein-carbohydrate interactions, forming
the three-dimensional meshworks (Figure 1). The ECM serves
not only as a physical scaffold for tissue construction, but also
as a dynamic field of signaling that regulates the behavior of
cells. In the meshwork of ECM, various signal molecules such as
growth factors and chemokines are stored, and the concentration
gradients of morphogens such as BMPs and Wnts are also
formed. The ECM also serves as an adhesive substrate for the
cells, regulating their motility and shape. The structures of ECM
are not fixed and static, but are dynamically reorganized by the
biosynthesis of its components and their degradation by various
proteases and glycanases. Thus, the dynamics of the ECM is
quite important in the regulation of cell growth, differentiation,
migration, adhesion and tissue morphogenesis.
Unlike other organs, the brain does not normally con-
tain fibrillar collagens except for the basal lamina surround-
ing the blood vessels and surface of the brain. Instead, major
components of brain ECM are proteoglycans. Until recently,
many neuroscientists had believed that the brain contains almost
FIGURE 1 | Schematic structure of extracellular matrix (ECM) in
the brain. The ECM of the brain is mainly composed of chondroitin
sulfate (CS) and heparan sulfate (HS) proteoglycans, hyaluronic acid
(HA), and glycoproteins such as tenascins. Lectican family CS
proteoglycans form large aggregates with HA and tenascins, which
store various proteins such as chemokines, growth factors and axon
guidance molecules. The ECM proteoglycans may bind with a CS/HS
receptor on the cell surface such as RPTPσ . Cell surface
proteoglycans may function as receptors or co-receptors for growth
factors.
no ECM, in spite of the early biochemical and histochemical
pioneering work by Margolis et al. (1975, 1976) and Nakanishi
(1983), showing the presence of a large amount of glycosamino-
glycans and proteoglycans in the developing brain. In the early
1990s, the brain-specific chondroitin sulfate proteoglycans were
biochemically characterized (Rauch et al., 1991; Maeda et al.,
1992; Oohira et al., 1994), and then their cDNAs were cloned
(Rauch et al., 1992; Maeda et al., 1994; Maurel et al., 1994;
Watanabe et al., 1995). Then, many investigations revealed the
importance of proteoglycans and ECM in the development and
disorders of the brain (Franco and Muller, 2011; Maeda et al.,
2011; Berretta, 2012; Soleman et al., 2013). However, even now, it
seems that the significance of ECM molecules is underestimated
in the field of neuroscience, except for reelin. It is desirable that
more and more neuroscientists pay attention to the brain ECM
molecules.
In this review, I will introduce the structure, binding partners
and assembly of proteoglycans and glycosaminoglycans, and dis-
cuss their roles in the neuronal migration in the cerebral cortex
and their emerging significance in human intellectual disability
and psychiatric disorders.
Assembly of Extracellular Matrix
Components
In the developing cerebral cortex, very high levels of ECM
molecules are expressed, the major components of which are
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chondroitin sulfate proteoglycans. Neurocan, versican, aggrecan,
and brevican are lectican family chondroitin sulfate proteogly-
cans expressed in the brain. Lecticans are secreted proteogly-
cans that bind with hyaluronic acid through the N-terminal
G1 domain that contains an immunoglobulin-like loop and
two link modules (Figure 2). These proteoglycans also have a
C-type lectin domain at the C-terminal, and chondroitin sul-
fate chains are covalently attached to the region between the
N- and C-terminal domains. The C-type lectin domain of lecti-
cans binds with tenascin family proteins by protein-protein inter-
action independent of the carbohydrate moiety (Aspberg et al.,
1997). Tenascin family proteins are oligomeric glycoproteins
with EGF-like repeats and fibronectin-III domains. The brain
contains hexameric tenascin-C and trimeric tenascin-R, which
promote the assembly of lecticans by protein-protein interac-
tion. On the other hand, hyaluronic acid is a very long polysac-
charide consisting of repeating disaccharides of glucuronic acid
(GlcA) and N-acetylglucosamine (GlcNAc), which are polymer-
ized at the plasma membrane by hyaluronan synthases (HASs).
Hyaluronic acids are anchored in the plasma membrane through
HASs, or bound to hyaluronan receptors on the cell surface, such
as CD44 and RHAMM (Figure 1). The tenascin-lectican com-
plexes bind to the hyaluronic acids through the G1 domains of
lecticans, which is stabilized by link proteins (Haplns), forming
huge aggregates surrounding cells (Figure 1). It is considered that
these huge aggregates serve as a basic framework to construct the
ECM in the brain.
Besides secreted chondroitin sulfate proteoglycans, there are
also cell surface proteoglycans. PTPζ /RPTPβ and neuroglycan
C are major cell surface chondroitin sulfate proteoglycans with
a membrane-spanning region. PTPζ is a receptor-type pro-
tein tyrosine phosphatase that is synthesized as a chondroitin
sulfate proteoglycan (Krueger and Saito, 1992; Maeda et al.,
1994). PTPζ has an N-terminal carbonic anhydrase-like domain,
a fibronectin-III domain, a membrane-spanning region and
two C-terminal tyrosine phosphatase domains. The extracellu-
lar domain of this receptor generated by alternative splicing
is secreted as a major soluble chondroitin sulfate proteogly-
can in the developing brain, phosphacan (Maurel et al., 1994).
Phosphacan binds with multiple proteins including pleiotrophin,
midkine, tenascins, contactin, and NCAM (Peles et al., 1998).
Neuroglycan C is a transmembrane chondroitin sulfate proteo-
glycan with an EGF module at the juxtamembrane region of
the extracellular domain (Watanabe et al., 1995). Chondroitin
sulfate-modification of neuroglycan C is developmentally and
regionally regulated, and the expression of the non-proteoglycan
form increases with development (Aono et al., 2004).
Another major group of proteoglycans in the developing ner-
vous system is heparan sulfate proteoglycans: syndecans and
glypicans (Figure 2). The syndecan family is composed of four
members, syndecan-1 to -4, each of which has an extracellu-
lar domain, a transmembrane region and a conserved short
C-terminal cytoplasmic domain (Lambaerts et al., 2009). The
N-terminal portion of the extracellular domain of syndecans is
FIGURE 2 | Schematic structures of proteoglycans. Phosphacan and
lectican family chondroitin sulfate (CS) proteoglycans are major
constituents of brain extracellular matrix. PTPζ is a CS
proteoglycan-type protein tyrosine phosphatase, which is a splice variant
of phosphacan. Neuroglycan C is a transmembrane CS proteoglycan
that is classified as Neuregulin-6. Glypicans are a family of
glycosyl-phosphatidylinositol (GPI)-anchored heparan sulfate (HS)
proteoglycans. Syndecans are a family of transmembrane HS
proteoglycans, some members of which may also be modified by CS
chains. Testicans are a family of secreted CS/HS proteoglycans.
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modified with heparan sulfate chains. The extracellular domains
of syndecan-1 and -4 may be additionally decorated with chon-
droitin sulfate chains near the transmembrane region (Deepa
et al., 2004). It has been considered that most of the extracel-
lular ligand molecules interact with syndecans through binding
with heparan sulfate portions. The transmembrane domains of
syndecans play important roles in their ligand-induced multi-
merization and the subsequent signaling (Choi et al., 2005). The
intracellular domains of syndecans are divided into two con-
served regions (C1 and C2) and a variable region (V), which
interact with various kinases and intracellular cytoplasmic com-
ponents such as src family kinases, CASK, and syntenin (Lam-
baerts et al., 2009).
Glypicans are glycosyl-phosphatidylinositol (GPI)-anchored
heparan sulfate proteoglycans, composed of six family mem-
bers (glypican-1 to -6) carrying 2–5 heparan sulfate chains
(Filmus et al., 2008; Filmus and Capurro, 2014). Glypican-5
was reported also to be modified with chondroitin sulfate in
rhabdomyosarcoma cells (Li et al., 2011). The core proteins of
glypicans consist of an α-helical domain containing 14 evolution-
arily conserved Cys residues, a heparan sulfate-attachment region
near the C-terminus, and the C-terminal GPI-anchor attachment
signal sequence. Biochemical and genetic studies demonstrated
that glypicans bind and regulate Hedgehogs, Wnt, bone mor-
phogenetic proteins and fibroblast growth factors (FGFs) (Fil-
mus and Capurro, 2014). In particular, genetic studies using
Drosophila demonstrated that glypicans (Dally and Dally-like)
play critical roles in the gradient formation of morphogens
during wing development (Wu et al., 2010; Raftery and Umulis,
2012). Although it has long been believed that the core proteins
of glypicans adopt a globular shape, a recent X-ray crystallo-
graphic study indicated that the structure of glypican-1 is actually
cylindrical (Svensson et al., 2012).
Testicans are extracellular chondroitin/heparan sulfate
proteoglycans, which have been poorly characterized to
date. They are composed of three family members (testican-
1 to -3), characterized by an N-terminal testican-specific
domain, a follistatin-like domain, an extracellular calcium-
binding domain, a thyroglobulin-like domain, and a domain
with glycosaminoglycan-attachment sites (Schnepp et al.,
2005).
Structure and Biosynthesis of Chondroitin
Sulfate and Heparan Sulfate
Chondroitin sulfate and heparan sulfate are unbranched sul-
fated polysaccharides covalently attached to the serine residues
in proteoglycan core proteins via common linkage tetrasac-
charides, GlcAβ1-3galactose(Gal)β1-3Galβ1-4xylose(Xyl)β1-O-
Ser (Figure 3). Chondroitin sulfate is composed of repeating
disaccharide units ofN-acetylgalactosamine (GalNAc) and GlcA,
(GlcAβ1-3GalNAcβ1-4)n, whereas heparan sulfate is composed
of repeating disaccharide units of GlcNAc and GlcA, (GlcAβ1-
4GlcNAcα1-4)n. Biosynthesis of these polysaccharides is initiated
by the addition of Xyl residues to the specific serine residues in
FIGURE 3 | Biosynthesis of glycosaminoglycans. (A) Chondroitin
sulfate (CS) and heparan sulfate (HS) chains are covalently attached to
the proteoglycan core proteins through a common linkage
tetrasaccharide. It is considered that the biosynthesis of a chondroitin
chain starts with the addition of an N-acetylgalactosamine (GalNAc)
residue to the linkage tetrasaccharide by CS
N-acetylgalactosaminyltransferases (CSGalNAcT1, 2). After that,
glucuronic acid (GlcA) and GalNAc residues are co-polymerized by
chondroitin sulfate synthases (CHSY-1, -2, -3) and chondroitin
polymerization factor (CHPF). When an N-acetylglucosamine (GlcNAc)
residue is added to the linkage tetrasaccharide instead of GalNAc by
EXTL 2 or 3, a heparan chain is polymerized by EXT family members.
(B) After polymerization, they are modified by sulfation and epimerization
reactions by many glycosaminoglycan modifying enzymes.
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core proteins by xylosyl transferases (XYLT1, 2) (Nadanaka and
Kitagawa, 2008; Mikami and Kitagawa, 2013; Mizumoto et al.,
2013a). This is followed by the addition of two Gal residues
and a GlcA residue by galactosyltransferase-I (B4GALT7),
galactosyltransferase-II (B3GALT6) and glucuronyltransferase-
I (B3GAT3), respectively. After that, repeating disaccharide
units of chondroitin or heparan sulfate are polymerized
in the Golgi apparatus. Chondroitin sulfates are polymer-
ized by chondroitin sulfate synthases (CHSY-1 to -3), chon-
droitin polymerization factor (CHPF) and chondroitin sulfate
N-acetylgalactosaminyltransferases (CSGalNAcT-1, -2), whereas
heparan sulfates are polymerized by EXT family members (EXT1,
EXT2, EXTL1, EXTL2, EXTL3). Since these glycosaminoglycans
use a common linkage tetrasaccharide, the chain initiation step
determines whether a chondroitin or a heparan chain elongates.
If the first GalNAc residue is added to the linkage tetrasaccharide
possibly by CSGalNAcT-1 or -2, a chondroitin chain is elongated
by the CHSY/CHPF complex. If a GlcNAc residue is alterna-
tively added to the linkage tetrasaccharide possibly by EXTL 2
or 3, a heparan chain is polymerized by the EXT1/EXT2 com-
plex. Although the genes encoding these biosynthetic enzymes
have been identified, almost nothing is known about the mech-
anism for the selection of glycosaminoglycan types at the chain
initiation step.
After the polymerization of repeating disaccharides, they are
heavily modified by the C5 epimerization of GlcA residues
and sulfation reactions (Nadanaka and Kitagawa, 2008; Mikami
and Kitagawa, 2013; Mizumoto et al., 2013a) (Figure 3). The
majority of the GalNAc residues in chondroitin sulfate are
4-O-sulfated by chondroitin 4-O-sulfotransferases (C4ST-1 to -
3) or 6-O-sulfated by 6-O-sulfotransferases (C6ST-1 and -2).
Although many of the disaccharide units in chondroitin sul-
fate are mono-sulfated A units [GlcAβ1-3GalNAc(4-SO4)] or C
units [GlcAβ1-3GalNAc(6-SO4)], they may be further sulfated by
GalNAc 4-sulfate 6-O-sulfotransferase (GalNAc 4S-6ST) or chon-
droitin uronyl 2-O-sulfotransferase (UST), generating di-sulfated
disaccharides, E units [GlcAβ1-3GalNAc(4, 6-bis-SO4)] or D
units [GlcA(2-SO4)β1-3GalNAc(6-SO4)], respectively. Further-
more, some of the GlcA residues are C5-epimerized to iduronic
acid (IdoA) by dermatan sulfate epimerases 1 and 2 (encoded
by DSE and DSEL, respectively). The resulting IdoAα1-3GalNAc
units are sulfated by dermatan 4-O-sulfotransferase (D4ST), gen-
erating an iA unit [IdoAα1-3GalNAc(4-SO4)], which may be
further sulfated by UST, generating an iB unit [IdoA(2-SO4)α1-
3GalNAc(4-SO4)]. Chondroitin sulfate with a high content of
IdoA is often called dermatan sulfate.
The modification of heparan sulfate begins with the
N-sulfation reaction by N-deacetylase/N-sulfotransferase
(NDST-1 to -4), which removes acetyl groups from some of
the GlcNAc residues in the heparan sulfate chain and replaces
them with sulfate groups (Figure 3). Then, some of the GlcA
residues are C5 epimerized to IdoA by heparan sulfate glu-
curonyl C5-epimerase (HS C5-EP), followed by O-sulfation
reactions. The O-sulfation includes 2-O-sulfation of GlcA/IdoA
residues by heparan sulfate 2-O-sulfotransferase (H2ST), 3-
O-sulfation of glucosamine (GlcN) units by heparan sulfate
3-O-sulfotransferases (H3ST-1, -2, -3A, -3B, -4, -5, and -6),
and 6-O-sulfation of GlcN units by heparan sulfate 6-O-
sulfotransferases (H6ST-1 to -3). Because N-sulfation of GlcN
units by NDSTs generates substrates for the subsequent modifi-
cation enzymes, highly N-sulfated regions in heparan sulfate are
also highly modified by C5-EP and various O-sulfotransferases.
Thus, heparan sulfate chains display domain structures: highly
modified NS-domains, poorly modified NA-domains charac-
terized by stretches of N-acetylated disaccharide units, and the
interspacing NA/NS-domains composed of both N-acetylated
and N-sulfated disaccharide units.
Binding Partners of Glycosaminoglycans
Recent studies using microarrays and surface plasmon resonance
revealed that chondroitin sulfate and heparan sulfate chains
bind with many proteins that play important roles in brain
development, especially neuronal migration (Deepa et al., 2002;
Kawashima et al., 2002; Maeda et al., 2006; Shipp and Hsieh-
Wilson, 2007; Conrad et al., 2010; Rogers et al., 2011; Mizumoto
et al., 2013b). Both heparan sulfate and chondroitin sulfate chains
bind with various axon guidancemolecules in a sulfation pattern-
dependent manner (Shipp and Hsieh-Wilson, 2007). While Slit2
shows a preference for heparan sulfate sequences that contain
6-O-sulfation and N-sulfation, netrin 1 requires sulfation at the
2-O-, 6-O-, andN-positions. Semaphorin5B (Sema5B), ephrinA1
and ephrinA5 prefer 2-O- andN-sulfation. On the other hand, all
of these axon guidance molecules bind strongly with E unit-rich
highly sulfated chondroitin sulfate E from squid cartilage (CS-E)
(Shipp and Hsieh-Wilson, 2007). Sema5B also binds moderately
with D unit-rich shark cartilage chondroitin sulfate D (CS-D),
and weakly with A unit-rich whale cartilage chondroitin sulfate A
(CS-A), pig skin dermatan sulfate (CS-B) and C unit-rich shark
cartilage chondroitin sulfate C (CS-C). EphrinA1 binds moder-
ately with CS-C, and weakly with CS-B and CS-D. Slit2, netrin1
and ephrinA5 bind only weakly with CS-A, -C, -D, and -B. In
addition, it has been reported that Sema3A binds strongly with
CS-E (Dick et al., 2013). EphrinA3 also binds with heparan sul-
fate and chondroitin sulfate, although the structural requirement
is unknown (Irie et al., 2008; Conrad et al., 2010).
Neurotrophin family growth factors [nerve growth fac-
tor (NGF), brain-derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4)] bind
strongly with CS-E (Rogers et al., 2011). BDNF, NT-3, and NT-4,
but not NGF bind moderately with CS-A, whereas CS-C shows
almost no binding to these proteins. PC12 cells express E unit-
rich chondroitin sulfate, and its removal upon chondroitinase
ABC treatment significantly attenuated TrkA activation by NGF
or NT-4, suggesting that endogenous chondroitin sulfate plays
important roles in neurotrophin signaling (Rogers et al., 2011).
Glial cell line-derived neurotrophic factor (GDNF) associates
with heparan sulfate in a 2-O-sulfation-dependent manner,
promoting the binding of this protein to its receptor component
GFRα1 (Rickard et al., 2003).
Chemokines are a family of small proteins that induce chemo-
taxis of various cells including cortical interneurons (Marin,
2013). Glycosaminoglycans interact with chemokines such as
CCL2 (MCP-1), CCL5 (RANTES), and CXCL12 (SDF-1) in a
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chain length- and sulfation pattern-dependent manner (Kuschert
et al., 1999; Hirose et al., 2001). Among the chemokines, CXCL12
plays important roles in the tangential migration of cortical
interneurons (see below). CXCL12 binds strongly with CS-E and
the highly sulfated S domains in heparan sulfate, and also inter-
acts weakly with CS-A, -B, -C, and -D (Murphy et al., 2004;
Mizumoto et al., 2013b). In addition, it was revealed that versi-
can interacts with CXCL12 through chondroitin sulfate chains
(Hirose et al., 2001). It has been considered that these interac-
tions in the ECM and cell surface contribute to the formation of
immobilized or haptotactic gradients of chemokines (Kuschert
et al., 1999).
Pleiotrophin and midkine are a family of multifunctional
heparin-binding growth factors that bind with both heparan sul-
fate and chondroitin sulfate (Perez-Pinera et al., 2007; Mura-
matsu, 2014). These growth factors bind strongly with highly
sulfated heparan sulfate and CS-E, moderately to CS-B and CS-
D, and very weakly to CS-A (Maeda et al., 2003; Zou et al., 2003;
Mizumoto et al., 2013b).
The structures of glycosaminoglycans are determined at
least partly by the combinatorial expression of their modifying
enzymes. During development of the brain, the sulfotrans-
ferases involved in the chondroitin/heparan sulfate synthesis
show dynamic spatiotemporal expression patterns (Yabe et al.,
2005; Mitsunaga et al., 2006; Ishii and Maeda, 2008b). This
suggests that the expression of specific functional domains
in these glycosaminoglycan chains is strictly regulated in
the developing brain. Conway et al. (2011) showed that the
expressions of HS2ST and HS6ST-1 are distinctively regu-
lated at the optic chiasm, and the mutant mice lacking these
genes exhibit different axon guidance defects. Interestingly,
HS2ST−/− and HS6ST-1−/− phenotypes closely match those
of Slit1−/− and Slit2−/−, respectively, suggesting that slit fam-
ily proteins are regulated by specific sulfation of heparan
sulfate.
Ligand Binding to Proteoglycans
As described above, glycosaminoglycans bind with various pro-
tein ligands in a structure-dependent manner. However, the lig-
and binding to proteoglycans is extremely complex becausemany
proteoglycans carry multiple glycosaminoglycan chains that may
function cooperatively. Furthermore, cooperation between the
core protein and attached glycosaminoglycan chains may also
occur. Accordingly, proteoglycans usually exhibit much higher
affinity and/or avidity for the ligand proteins than free gly-
cosaminoglycans (Herndon et al., 1999). Thus, degradation of
proteoglycan core proteins by extracellular proteases may termi-
nate such cooperativity and release the ligand molecules, leading
to the activation or inactivation of the signaling in a context-
dependent manner. Cooperation is observed not only between
glycosaminoglycans of the same type but also between hep-
aran sulfate and chondroitin sulfate chains. Syndecan-1 and
syndecan-4 carry both heparan sulfate and chondroitin sulfate
chains, which cooperatively regulate the binding dynamics of
pleiotrophin, midkine and FGF-2 to these proteoglycans (Deepa
et al., 2004).
PTPζ /phosphacan binds to pleiotrophin and midkine, in
which both chondroitin sulfate and core protein portions con-
tribute to the interaction (Maeda et al., 1996, 1999, 2003). While
intact phosphacan preparation shows low (Kd = 3 nM) and high
affinity binding (Kd = 0.25 nM) for pleiotrophin, this proteogly-
can exhibits only single very low affinity binding after chondroiti-
nase ABC-treatment (Kd = 13 nM) (Maeda et al., 1996). This
suggests that the binding affinity of phosphacan for pleiotrophin
is regulated by the structural variation of chondroitin sulfate. In
fact, the structure of chondroitin sulfate on phosphacan changes
during rat brain development, and a slight increase in the content
of oversulfated D unit drastically strengthens the binding of this
proteoglycan to pleiotrophin (Maeda et al., 2003).
Another prominent example of the cooperation between the
core protein and glycosaminoglycan chain in the signaling has
been reported by the group of Filmus (Li et al., 2011; Fil-
mus and Capurro, 2014). They revealed that glypican-3 and
glypican-5 oppositely regulate the Hedgehog (Hh) signaling in
rhabdomyosarcoma cell proliferation. Glypican-3 binds to Hh
through its core protein, reducing the amount of Hh available
to its receptor Patched 1 (Ptc1), with the consequent decrease in
signaling. On the other hand, glypican-5 interacts with both Hh
and Ptc1 through heparan sulfate and chondroitin sulfate chains,
facilitating Hh-Ptc1 binding with the consequent increased sig-
naling. The heparan sulfate chains of glypican-5 show a higher
degree of sulfation than those of glypican-3, which may explain
why the glycosaminoglycan chains of glypican-5 but not those of
glypican-3 interact with Hh/Ptc1.
Sema5A is an axon guidance molecule that can exert both
inhibitory and permissive effects on growing axons. Kantor et al.
(2004) revealed that Sema5A interacts with the glycosamino-
glycan portion of both chondroitin sulfate and heparan sul-
fate proteoglycans. The axonal heparan sulfate proteoglycans are
required for the Sema5A-mediated attraction of growing axons
of the fasciculus retroflexus. On the other hand, the extracellular
chondroitin sulfate proteoglycans precisely localize Sema5A in a
specific area, where Sema5A acts as a repulsive guidance cue for
these growing axons. Thus, the bifunctional roles of Sema5A are
regulated by chondroitin sulfate and heparan sulfate proteogly-
cans, demonstrating the cooperation among these two types of
proteoglycans during the process of axon pathfinding.
Recently, Coles et al. (2011) reported that receptor protein
tyrosine phosphatase σ (RPTPσ ) is a receptor for both chon-
droitin sulfate and heparan sulfate proteoglycans. Heparan sul-
fate proteoglycans induce oligomerization of RPTPσ on the
growth cone, leading to inactivation of the tyrosine phosphatase
activity and growth promotion. On the other hand, extracellu-
lar chondroitin sulfate proteoglycans inhibit oligomerization of
this receptor with consequent suppression of axon growth. It is
considered that multiple RPTPσ molecules bind to the islands
of high/intermediate sulfation on heparan sulfate chains (NS to
NA/NS domains), which stabilize the receptor oligomers. Con-
versely, the receptor binding sites are considered to be sparsely
distributed on chondroitin sulfate chains, and therefore recep-
tor oligomerization cannot occur. If so, the signaling of RPTPσ
should be highly dependent on the glycosaminoglycan structures.
Proteoglycans bearing low sulfated heparan sulfate chains may
Frontiers in Neuroscience | www.frontiersin.org 6 March 2015 | Volume 9 | Article 98
Maeda Proteoglycans in brain
inhibit receptor oligomerization, and conversely proteoglycans
bearing highly sulfated chondroitin sulfate may induce recep-
tor oligomerization. It is also reported that another receptor
tyrosine phosphatase, leukocyte common antigen-related phos-
phatase (LAR) is a functional receptor for chondroitin sulfate
proteoglycan (Fisher et al., 2011).
Although the structure of glycosaminoglycans is basically
determined by the biosynthetic processes, the sulfation pattern
of heparan sulfate may be modified extracellularly by the endo-
sulfatases, Sulf1 and Sulf2 (Nagamine et al., 2012). These sulfa-
tases catalyze the desulfation of the 6-O-sulfate group from GlcN
residues in the trisulfated disaccharides in heparan sulfate. Thus,
highly sulfated NS domains in heparan sulfate are preferentially
desulfated by these enzymes, leading to the change in the bind-
ing affinity of various ligands to heparan sulfate proteoglycans.
This results in the activation or suppression of specific signaling
molecules such as Wnt, GDNF, and FGF during various develop-
mental processes (Ai et al., 2003, 2007; Wang et al., 2004). Thus,
functions of proteoglycans are intricately regulated at multiple
levels.
Roles of Proteoglycans in Neuronal
Migration
In the developing neocortex, postmitotic pyramidal neurons gen-
erated in the ventricular zone show a multipolar shape, and
migrate in random directions in the subventricular and interme-
diate zones (Figure 4). After that, they transform into the bipolar
shape and attach to the radial glial fibers, upon which they rapidly
migrate toward the marginal zone. This multipolar-to-bipolar
transition occurs when the neurons reach the subplate, suggest-
ing that this layer contains critical factor(s) regulating neuronal
behavior (Ohtaka-Maruyama et al., 2013). The radial migra-
tion of pyramidal neurons stops at the interface between the
cortical plate and the marginal zone, forming the “inside-out”
arrangement of neurons. On the other hand, inhibitory neurons
tangentially migrate in the neocortex through the marginal zone,
subplate, and lower intermediate/subventricular zones. These
migration patterns of both excitatory and inhibitory neurons sug-
gest that specific cortical layers play critical roles in the regula-
tion of neuronal migration. Nakanishi (1983) demonstrated that
glycosaminoglycans stained by colloidal iron distributed princi-
pally in the marginal zone and subplate in the developing mouse
cerebral cortex. In the cortices of reeler mutants, where radial
migration of pyramidal neurons is severely disturbed, most gly-
cosaminoglycans are localized in the outer layer of the cortex.
From such an expression pattern, it was suggested that gly-
cosaminoglycans are involved in the neuronal migration and/or
laminar pattern formation of the neocortex. Then, the brain-
specific chondroitin sulfate proteoglycans were identified, and it
was revealed that neurocan and phosphacan are richly expressed
in the marginal zone and subplate (Oohira et al., 1994; Maeda
et al., 1995; Meyer-Puttlitz et al., 1996) (Figure 5). Versican was
also localized in these layers (Popp et al., 2003), raising the pos-
sibility that chondroitin sulfate proteoglycans regulate neuronal
migration in the cortex.
As described above, PTPζ /phosphacan binds to pleiotrophin
with high affinity (Maeda et al., 1996, 1999). Pleiotrophin induces
oligomerization of PTPζ , which leads to the inactivation of its
FIGURE 4 | Migration routes of excitatory and inhibitory neurons in
the cerebrum. (A) The excitatory neurons are generated in the
ventricular zone of the neocortex (Ctx) and migrate radially toward the
brain surface (red arrow). The cortical inhibitory neurons are generated
mainly in the medial ganglionic eminence (MGE), and migrate tangentially
toward the neocortex (blue arrows). The migrating interneurons avoid
the striatum (Str) that expresses chondroitin sulfate proteoglycans
(CSPG) and semaphorin 3A (Sema 3A). (B) In the neocortex, the
excitatory neurons (red cells) born in the ventricular zone (VZ) show
multipolar morphology and migrate in random directions (Mp) in the
subventricular (SVZ) and intermediate (IZ) zones. When the multipolar
neurons reach the subplate (SP), they transform into a bipolar shape
and migrate radially (Rm) in the cortical plate (CP) toward the marginal
zone (MZ). On the other hand, the tangential migration (Tm) of
interneurons (blue cells) occurs in a layer-specific manner, in which
interneurons prefer MZ, SP, lower IZ, and SVZ.
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FIGURE 5 | Immunohistochemical localization of neurocan and
phosphacan. The frontal sections of embryonic day 16 rat brains were
immunohistochemically stained with anti-neurocan (A) and anti-phosphacan
(B) monoclonal antibodies. They are selectively expressed in the marginal zone
(arrowheads) and subplate (arrows) in the neocortex, and the striatum (Str).
The medial (MGE) and lateral (LGE) ganglionic eminences are negative.
tyrosine phosphatase activity, initiating downstream signaling
(Meng et al., 2000; Fukada et al., 2006). Pleiotrophin is deposited
along radial glial fibers, and PTPζ is expressed on the migrat-
ing pyramidal neurons, raising the possibility that pleiotrophin
on radial glial fibers regulates the radial migration of excitatory
neurons (Maeda and Noda, 1998). In fact, in vitro cell migration
assay demonstrated that pleiotrophin-PTPζ signaling induces
migration of cortical neurons (Maeda and Noda, 1998). Subse-
quently, this signaling system has been demonstrated to promote
the migration of various types of normal and tumor cell in a
chondroitin sulfate-dependent manner (Polykratis et al., 2005;
Feng et al., 2010; Koutsioumpa et al., 2013). Phosphacan and
free chondroitin sulfate suppress the pleiotrophin-induced neu-
ronal migration by competitive inhibition of the binding between
pleiotrophin and cell surface PTPζ (Maeda and Noda, 1998;
Maeda et al., 1999). Soluble chondroitin sulfate proteoglycans
such as phosphacan, neurocan and versican expressed in the sub-
plate and marginal zone may regulate the migratory behavior of
neurons by inhibiting pleiotrophin- PTPζ signaling.
Recently, it was found that neuroglycan-C is involved in
the radial migration of pyramidal neurons from a study of the
plant homeodomain (PHD) finger 6 (PHF6) gene (Zhang et al.,
2013). PHF6 is an X-linked gene encoding the protein that has
four nuclear localization signals and two PHD-type zinc finger
domains, which functions as a transcription repressor. Mutations
of PHF6 cause Börjeson-Forssman-Lehmann syndrome, charac-
terized by intellectual disability associated with seizures, short
stature, hypogonadism, hypometabolism, marked gynecomastia,
truncal obesity, tapered fingers, narrow palpebral fissure, and
large ears (Liu et al., 2014). Using in utero electroporation, Zhang
et al. (2013) demonstrated that knockdown of PHF6 severely
impaired the radial migration of cortical neurons. They also iden-
tified neuroglycan-C as a downstream target of PHF6. Knock-
down of neuroglycan-C phenocopied the neuronal migration
phenotype of PHF6 knockdown, suggesting that PHF6 controls
the expression level of neuroglycan-C in the cortical neurons,
thus regulating the radial neuronal migration. Neuroglycan C
binds with pleiotrophin and midkine, in which its chondroitin
sulfate portion increases the affinity of the core protein for
these growth factors (Ichihara-Tanaka et al., 2006; Nakanishi
et al., 2010). There is a possibility that pleiotrophin/midkine-
neuroglycan C signaling is involved in the radial migration in the
cerebral cortex.
Pleiotrophin also binds with syndecan-3 in a heparan sulfate-
dependent manner (Raulo et al., 1994; Kinnunen et al., 1996).
Like PTPζ , syndecan-3 is required for pleiotrophin-induced neu-
ronalmigration, suggesting that PTPζ and syndecan-3 are redun-
dant pleiotrophin receptors on cortical neurons (Hienola et al.,
2006). Syndecan-3 knockout mice showed delayed radial neu-
ronal migration in the cortex, and this delay was partially caught
up at ∼10 days after birth (Hienola et al., 2006). The binding of
pleiotrophin to syndecan-3 triggers the phosphorylation of src,
which then activates cortactin and modulates the assembly of the
actin cytoskeleton. Syndecan-3 knockout mice also show migra-
tion defects of interneurons (Bespalov et al., 2011). At embry-
onic day 15, calbindin-positive precursors of interneurons were
accumulated in the ganglionic eminence of syndecan-3 knock-
out mice, and the density of GABA-immunoreactive cells was
lower in the dorsomedial cortex of adult knockout mice than
in that of control mice. It has been suggested that GDNF binds
to the heparan sulfate portion of syndecan-3 on interneurons,
promoting their migration. On the other hand, syndecan-1 is
expressed by the neural progenitor cells in the cerebral cortex
(Wang et al., 2012). Knockdown of syndecan-1 using in utero
electroporation resulted in the reduction of neural progenitor
cells and the promotion of neuronal differentiation in the cor-
tex (Wang et al., 2012). In these cortices, there were fewer cells
in the ventricular/subventricular zone, and more neurons moved
into the intermediate zone and cortical plate compared with the
cortices electroporated with control plasmid. These findings sug-
gest that syndecan-1 and syndecan-3 are differentially expressed
and play distinct roles in the developing cortex.
Roles of Glycosaminoglycans in Neuronal
Polarization
During development of the mouse cerebrum, the disaccharide
composition of chondroitin sulfate changes dynamically (Ishii
and Maeda, 2008a). At embryonic day 16 (E16), the major com-
ponents are A and C units, and then the content of A unit
increases and that of C unit decreases until maturation. A small
but significant amount of E unit is detected at E16 to 18, and
the content decreases thereafter. D unit is a minor compo-
nent, but is constantly detected during embryonic and postna-
tal development. Since D and E units contribute significantly to
the binding of various ligand molecules as described above, we
investigated the roles of these oversulfated structures in neuronal
migration (Ishii and Maeda, 2008a). Using in utero electropora-
tion, we introduced shRNA constructs for GalNAc 4S-6ST and
UST into neural progenitor cells in the ventricular zone of the
E14 cortex. At E18, the embryos were dissected out, and the
migration of the cortical neurons was examined. Knockdown of
both sulfotransferases severely disrupted the radial migration of
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cortical neurons. The neurons knocked down for these enzymes
were accumulated in the subventricular zone and in the inter-
mediate zone, and showed multipolar morphology. This sug-
gested that oversulfated chondroitin sulfate is required for the
multipolar-to-bipolar transition of pyramidal neurons.
Neuronal polarization of dissociated hippocampal pyramidal
cells is a well-established in vitro model of multipolar-to-bipolar
transition of newborn neurons (Dotti et al., 1988). Dissociated
hippocampal pyramidal neurons extend several morphologically
indistinguishable minor processes several hours after plating.
Then, one of these minor processes extends rapidly and becomes
an axon, and the other processes differentiate into dendrites.
In contrast, the hippocampal neurons cultured in the pres-
ence of chondroitinase ABC extended multiple axon-like pro-
cesses that were highly unstable and repeatedly extended and
retracted (Nishimura et al., 2010). The morphology and behav-
ior of the chondroitinase ABC-treated neurons were similar to
those of multipolar neurons in the developing cortex. Further-
more, knockdown of GalNAc 4S-6ST and UST also disturbed
the neuronal polarization of cultured hippocampal neurons, sug-
gesting the importance of oversulfated chondroitin sulfate in
this process. In the cultured hippocampal neurons, the oversul-
fated chondroitin sulfate was accumulated in the focal contacts
in the cell bodies and axons. Chondroitinase ABC-treatment sup-
pressed the tyrosine phosphorylation of FAK at the focal contacts,
suggesting that the proteoglycans bearing oversulfated chon-
droitin sulfate strengthen the adhesion of axons and cell bodies
to the substrate, leading to the stabilization of neuronal mor-
phology. In contrast to the chondroitinase ABC-treatment, the
axons extended steadily and showed almost no retraction when
hippocampal neurons were treated with heparitinases that specif-
ically degrade heparan sulfate. This suggests that heparan sulfate
proteoglycans destabilize the neuronal morphology, inducing
retraction of axons. In fact, it has been reported that heparan sul-
fate proteoglycans on growth cones are essential for the repulsive
activities of Slit2 and ephrin-A3 (Hu, 2001; Irie et al., 2008). Thus,
chondroitin sulfate and heparan sulfate proteoglycans expressed
on hippocampal neurons play opposing roles during neuronal
polarization.
Roles of Glycosaminoglycans in Tangential
Neuronal Migration
Cortical interneurons are born in themedial ganglionic eminence
(MGE), caudal ganglionic eminence and preoptic area in the ven-
tral telencephalon, and migrate tangentially toward the cortex
(Evsyukova et al., 2013; Marin, 2013) (Figure 4). The newborn
interneurons exiting the ganglionic eminence avoid entering the
striatum, and migrate into the neocortex through the marginal
zone, subplate, or lower intermediate/subventricular zones, sug-
gesting that complex interplay of repulsive and attractive cues
regulates the migration route of these neurons. Neuregulin-1,
NT-4, and GDNF were shown to be chemoattractive factors
for cortical interneurons, whereas Slit 1, Sema 3A, ephrin a3,
and ephrin a5 act as chemorepulsive factors (Zhu et al., 1999;
Polleux et al., 2002; Flames et al., 2004; Rudolph et al., 2010;
Bespalov et al., 2011; Marin, 2013; Steinecke et al., 2014). As
described above, biochemical studies revealed that these fac-
tors bind with chondroitin and/or heparan sulfate in a sulfa-
tion pattern-dependent manner. Thus, there is a possibility that
chondroitin/heparan sulfate proteoglycans regulate the spatial
distribution and/or activity of these factors. In fact, a recent
report demonstrated that chondroitin sulfate plays an impor-
tant role in the tangential migration of interneurons (Zim-
mer et al., 2010). Chondroitin sulfate proteoglycans are highly
expressed in the striatal mantle zone, which is avoided by
tangentially migrating interneurons (Figure 5). In vitro Boy-
den chamber cell migration and stripe assays demonstrated
that chondroitin sulfate proteoglycans exert repulsive effects on
cortical interneurons. These repulsive effects were suppressed
by chondroitinase ABC-treatment, suggesting that chondroitin
sulfate directly acts as a repellent for these neurons. Further-
more, in the chondroitinase ABC-treated brain slices, corti-
cal interneurons actively invaded the striatum, although they
avoided this region in the control slices. Sema3A is retained
in the striatum by binding to the chondroitin sulfate chains,
and repels migrating interneurons that express Sema3A receptor,
neuropilin 1. Thus, it was shown that chondroitin sulfate proteo-
glycans exert not only direct, but also indirect repulsive effects
on interneurons by anchoring repulsive factors in the striatum
(Figure 4).
After the interneurons enter the neocortex, they avoid
the cortical plate, where chondroitin sulfate proteoglycans are
poorly expressed (Figure 4). Instead, they migrate through the
chondroitin sulfate proteoglycan-rich marginal zone and sub-
plate. They also prefer the subventricular zone and the lower
intermediate zone, where the content of chondroitin sulfate pro-
teoglycans is relatively low. Thus, it seems that chondroitin sul-
fate proteoglycans do not act as a repellent for interneurons in
the neocortex. Tangential migration of interneurons in the neo-
cortex is induced by the chemokine CXCL12 (SDF1), which is
concentrated in the marginal zone, subplate, and lower interme-
diate/subventricular zones (Li et al., 2008; Lopez-Bendito et al.,
2008). It has been reported that CXCL12 binds with both chon-
droitin sulfate and heparan sulfate (Mbemba et al., 2000). The
marginal zone and subplate are highly enriched with phospha-
can, neurocan and versican (Oohira et al., 1994; Maeda et al.,
1995; Meyer-Puttlitz et al., 1996) (Figure 5), and thus CXCL12
may be anchored to the chondroitin sulfate chains of these pro-
teoglycans. On the other hand, syndecan-1 is highly expressed
in the ventricular/subventricular zone and in the lower interme-
diate zone (Wang et al., 2012), and may concentrate CXCL12
in these layers through heparan and/or chondroitin sulfate moi-
eties. Thus, it seems that proteoglycans can be either attractive
or repulsive substrates depending on the proteins bound to their
glycosaminoglycan chains.
As described above, syndecan-3 functions as a GDNF recep-
tor expressed on migrating interneuron (Bespalov et al., 2011). In
this case, only the matrix-bound form of GDNF acts as a ligand
of syndecan-3, and the soluble form is not active. It may be that
GDNF bound to the chondroitin/heparan sulfate proteoglycans
in the extracellular matrix activates the syndecan-3 signaling in
the interneurons.
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TABLE 1 | Human disorders caused by mutations of proteoglycan-related genes.
Genes (coded
proteins)
Clinical features References
XylT1
(Xylosyltransferase 1)
Autosomal recessive short stature syndrome; distinct facial features, alteration of fat distribution,
intellectual disability
Schreml et al., 2014
B3GALT6
(Galactosyltransferase II)
Pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder; skin fragility, delayed wound
healing, joint hyperlaxity, and contractures, muscle hypotonia, spondyloepimetaphyseal dysplasia,
intellectual disability
Malfait et al., 2013.
CHSY1
(Chondroitin synthase 1)
Temtamy preaxial brachydactyly syndrome; bilateral preaxial brachydactyly and hyperphalangism of
digits, facial dysmorphism, dental anomalies, sensorineural hearing loss, intellectual disability
Li et al., 2010.
NDST1
(NDST1)
Intellectual disability, muscular hypotonia, epilepsy, postnatal growth deficiency Reuter et al., 2014.
SPOCK1
(Testican-1)
Intellectual disability, partial agenesis of corpus callosum, prenatal-onset microcephaly, artrial septal
defects
Dhamija et al., 2014.
GPC3
(Glypican 3)
Simpson-Golabi-Behmel syndrome type I; pre/postnatal overgrowth, distinctive craniofacial
features, macrocephaly, organomegaly. Intellectual disability and epilepsy in some cases
Tenorio et al., 2014.
Proteoglycans, Psychiatric Disorders, and
Intellectual Disabilities
Since proteoglycans are major components of the connective
tissue, mutations in the proteoglycan-related genes cause var-
ious skeletal and connective tissue disorders (Huegel et al.,
2013; Mizumoto et al., 2013a). Recently, the involvement of
these genes in intellectual and psychiatric disorders has also
begun to be revealed (Tables 1, 2). A hypofunctional mutation
of XYLT1 encoding xylosyltransferase 1 causes an autoso-
mal recessive short stature syndrome associated with intellec-
tual disability (Schreml et al., 2014). Mutations of B3GALT6
encoding galactosyltransferase II cause a pleiotropic Ehlers-
Danlos-syndrome-like connective tissue disorder, which is also
associated with intellectual disability (Malfait et al., 2013). As
described above, these two enzymes are involved in the biosyn-
thesis of the linkage tetrasaccharides that are used commonly for
the chain initiation of chondroitin and heparan sulfates, imply-
ing that these glycosaminoglycans are essential for the devel-
opment of higher intellectual function of the brain. In fact, an
earlier study suggested that EXT1, encoding a heparan sulfate
co-polymerase, is associated with autism (Li et al., 2002). Loss-of-
function mutations in CHSY1 encoding chondroitin synthase 1
cause Temtamy preaxial brachydactyly syndrome, which is char-
acterized by delayed motor and mental development as well as
bilateral, symmetric preaxial brachydactyly and hyperphalangism
of digits, facial dysmorphism, and dental anomalies (Li et al.,
2010). Furthermore, it was found that missense mutations of
NDST1 cause intellectual disability, muscular hypotonia, and
epilepsy, suggesting that normal modification of heparan sulfate
is essential for the development of functional neuronal circuits
(Reuter et al., 2014).
In addition to glycosaminoglycan biosynthetic enzymes,
genes encoding proteoglycan core proteins are also asso-
ciated with intellectual disability. Missense mutation in
SPOCK1 encoding testican-1 causes intellectual disability
with dyspraxia, dysarthria, partial agenesis of corpus callo-
sum, and prenatal-onset microcephaly (Dhamija et al., 2014).
TABLE 2 | Proteoglycan-related genes proposed to be associated with
mental disorders.
Genes (coded
proteins)
Mental disorders References
DSEL
(DS epimerase 2)
Bipolar disorder, depressive
disorder
Goossens et al., 2003;
Shi et al., 2011
UST
(UST)
Job-related exhaustion Sulkava et al., 2013
NDST3
(NDST3)
Schizophrenia, bipolar disorder Lencz et al., 2013
EXT1
(EXT1)
Autism Li et al., 2002
NCAN
(Neurocan)
Schizophrenia, bipolar disorder Muhleisen et al., 2012;
Schultz et al., 2014
PTPRZ1
(Phosphacan/PTPζ )
Schizophrenia Buxbaum et al., 2008;
Takahashi et al., 2011
CSPG5
(Neuroglycan C)
Schizophrenia So et al., 2010
Simpson-Golabi-Behmel syndrome is an overgrowth/multiple
congenital anomalies syndrome caused by mutations in glypican
3. This disease shows high clinical variability, and in some cases,
intellectual disability is present (Tenorio et al., 2014). It will be
important to examine whether these intellectual disabilities are
caused by abnormal neuronal migration in the cortex.
It has recently been revealed that early developmental defects
of neural network formation including abnormal neuronal
migration and myelination can cause various psychiatric dis-
eases such as schizophrenia (Stolp et al., 2012). Muhleisen et al.
(2012) identified variation in the neurocan gene (rs1064395) as
a common risk factor for bipolar disorder and schizophrenia. In
schizophrenia patients, neurocan risk status was found to be asso-
ciated with higher folding in the right lateral occipital cortex and
left dorsolateral prefrontal cortex (Schultz et al., 2014). Neuro-
can may play important roles in the neuronal migration and/or
formation of axonal fibers in the cerebral cortex, and the deficits
in these processes may influence the folding of the occipital and
prefrontal lobes, leading to an increased risk of schizophrenia.
Frontiers in Neuroscience | www.frontiersin.org 10 March 2015 | Volume 9 | Article 98
Maeda Proteoglycans in brain
It is well known that several members of the Neuregulin/ErbB
signaling system are susceptibility genes of schizophrenia, bipo-
lar disorders and depression (Mei and Nave, 2014). Neureg-
ulins constitute a family of EGF-like signaling molecules that
stimulate ErbB receptor family tyrosine kinases, the signal-
ing of which regulates neuronal migration, myelination, neu-
rotransmission and synaptic plasticity (Mei and Nave, 2014).
Recent studies suggested that proteoglycans regulate Neureg-
ulin/ErbB signaling, and thus are related to psychiatric disorders.
Buxbaum et al. (2008) reported that PTPRZ1, which encodes
both PTPζ and phosphacan, is associated with schizophrenia in
a Caucasian population, although no association was found in
the Japanese population (Ito et al., 2008). They demonstrated
that PTPζ binds with ErbB4 through the scaffolding protein,
MAGI, and inhibits the Neuregulin-1/ErbB4 signaling. Further-
more, Takahashi et al. (2011) found that the expression of PTPζ
is increased in the brains of schizophrenia patients, and also
demonstrated that transgenic mice overexpressing PTPζ showed
reduced Neuregulin-1 signaling, and abnormal glutamatergic,
GABAergic and dopaminergic activity as well as delayed oligo-
dendrocyte development. In particular, it is remarkable that the
number of parvalbumin-positive interneurons is decreased in the
cortex of this transgenic mouse. Flames et al. (2004) demon-
strated that loss of Neuregulin-1/ErbB4 signaling causes an alter-
ation in the tangential migration of cortical interneurons and
reduction in the number of GABAergic interneurons in the post-
natal cortex. Therefore, PTPζ /phosphacan may negatively reg-
ulate Neuregulin-1/ErbB4 signaling, and inhibit the tangential
migration of cortical interneurons.
Neuroglycan C was identified as a potential susceptibility gene
for schizophrenia in a Southern Chinese population (So et al.,
2010). As described above, neuroglycan C is involved in the
radial neuronal migration in the neocortex (Zhang et al., 2013),
and thus defects in this process may be involved in the etiology
of schizophrenia. In addition, neuroglycan C has an EGF-like
domain, acts as a direct ligand for ErbB3, and thus is classified
as Neuregulin-6 (Kinugasa et al., 2004). It has been reported that
ErbB3 is associated with schizophrenia in a Caucasian popula-
tion (Li et al., 2009), and thus there is a possibility that neu-
roglycan C-ErbB3 signaling is involved in the pathophysiology
of schizophrenia. ErbB3 plays important roles in oligodendro-
cyte differentiation and myelination (Mei and Nave, 2014), and
neuroglycan C may regulate these processes. In this context, it
is interesting to note that midkine-neuroglycan C signaling pro-
motes process elongation of the oligodendrocyte precursor-like
cell line, CG-4 (Ichihara-Tanaka et al., 2006).
In addition to proteoglycan core proteins, glycosaminoglycan-
modifying enzymes have also been associated with psychiatric
disorders. A genome-wide association study revealed thatNDST3
is associated with schizophrenia and bipolar disorder, suggesting
that the sulfation pattern of heparan sulfate plays an important
role in the pathophysiology of these disorders (Lencz et al., 2013).
Neuregulin-1 binds with heparan sulfate in a sulfation pattern-
dependent manner, in which the N-sulfate group is the most
important (Pankonin et al., 2005). Thus, the N-sulfated region
in heparan sulfate may be important for normal Neuregulin-
1/ErbB4 signaling.
The genomic region containingDSEL encoding dermatan sul-
fate epimerase 2 has been found to be associated with bipolar
disorder (Goossens et al., 2003) and depressive disorder (Shi
et al., 2011). In addition, it was reported that UST is associated
with job-related exhaustion and response to antidepressant (Uher
et al., 2010; Sulkava et al., 2013). Thus, chondroitin sulfate proteo-
glycans bearing oversulfated dermatan/chondroitin sulfate may
play important roles in the etiology of mood disorders.
Perspective
As described above, brain proteoglycans regulate themigration of
both excitatory and inhibitory neurons by binding with various
proteins. Besides neuronal migration, proteoglycans play impor-
tant roles in the proliferation and differentiation of neural pro-
genitor cells, axon pathfinding, myelination, axon regeneration,
and maturation and plasticity of synapses (Maeda et al., 2011;
Soleman et al., 2013; Silver and Silver, 2014; Theocharidis et al.,
2014), the defects of which may be related to the pathogenesis
of various brain disorders. More mechanistic studies are nec-
essary to elucidate the relationship between proteoglycans and
these diseases. In this context, it should be noted that many extra-
cellular matrix proteins that interact with proteoglycans are over-
looked in the field of developmental neuroscience. These include
extracellular matrix proteases and their inhibitors such as MMP,
ADAMTS, ADAM, and Timp family members. Proteoglycans
turn over very rapidly in the developing brain, and their degrada-
tion would lead to drastic change in the distribution and activity
of growth factors, chemokines, axon-guidance molecules, and so
on. Thus, it is likely that degradation of proteoglycans would
profoundly influence the behavior of neurons. Future study is
necessary to shed light on this issue.
Finally, I would like to emphasize that the functions of pro-
teoglycans are regulated in a context-dependent manner. It is
often said that chondroitin sulfate proteoglycans are repulsive
molecules. However, this over-simplified view has been chal-
lenged by the finding that chondroitin sulfate proteoglycans such
as PTPζ and neuroglycan C promote the radial migration of
cortical neurons. Furthermore, chondroitin sulfate proteogly-
cans may function as either a repulsive or an attractive sub-
strate depending on the factors attached to the chondroitin sul-
fate chains. In addition, it should be noted that even though
the proteoglycan core protein is the same, the structures of the
attached glycosaminoglycan chains may be highly variable lead-
ing to the diversification of proteoglycan functions. I expect
that careful experimental design and interpretation of the results
would uncover the important functions of brain proteoglycans.
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